Production (Stage)
Emmaus Life Sciences, Inc.
EMMA
$0.017
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.21% | -72.86% | 26.28% | -1.08% | 63.06% |
| Total Depreciation and Amortization | -27.59% | -31.25% | -41.03% | -39.53% | -38.30% |
| Total Amortization of Deferred Charges | -87.38% | -72.43% | -42.78% | -19.30% | 24.87% |
| Total Other Non-Cash Items | -205.52% | -133.96% | -212.93% | -187.23% | -103.55% |
| Change in Net Operating Assets | 12.37% | 260.49% | 3,146.67% | 481.40% | -40.85% |
| Cash from Operations | -2,923.94% | -52.10% | -84.80% | 10.19% | 95.65% |
| Capital Expenditure | 46.67% | 29.41% | 36.84% | 31.58% | 50.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 274.33% | 704.34% | 270.73% | 207.06% | 114.33% |
| Cash from Investing | 282.29% | 678.70% | 267.74% | 205.38% | 113.92% |
| Total Debt Issued | -54.80% | -58.80% | -38.65% | -3.45% | -21.38% |
| Total Debt Repaid | 49.81% | 27.15% | -8.67% | -88.49% | -150.61% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -20.03% | -154.62% | -143.85% | -105.41% | -108.46% |
| Foreign Exchange rate Adjustments | 125.93% | -18.75% | -58.33% | 40.00% | -35.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -511.29% | -320.15% | -176.69% | -56.73% | -106.45% |